Search

everythinglearnresearchcommunity

for

Search:↓

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Hair care practices like using relaxers and tight braiding can lead to permanent hair loss in black women.

A mushroom extract might reduce hair loss and liver damage caused by certain chemotherapy drugs in animals.

PRP is effective for treating hair loss, especially with other treatments.

PRP improves hair transplant results in androgenetic alopecia patients.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

One session of Low Level Laser Therapy before hair transplantation doesn't significantly improve hair growth.